An immobilized liquid interface prevents device associated bacterial infection in vivo
Source abstract
Abstract
Virtually all biomaterials are susceptible to biofilm formation and, as a consequence, device-associated infection. The concept of an immobilized liquid surface, termed slippery liquid-infused porous surfaces (SLIPS), represents a new framework for creating a stable, dynamic, omniphobic surface that displays ultralow adhesion and limits bacterial biofilm formation. A widely used biomaterial in clinical care, expanded polytetrafluoroethylene (ePTFE), infused with various perfluorocarbon liquids generated SLIPS surfaces that exhibited a 99% reduction in S. aureus adhesion with preservation of macrophage viability, phagocytosis, and bactericidal function. Notably, SLIPS modification of ePTFE prevents device infection after S. aureus challenge in vivo, while eliciting a significantly attenuated innate immune response. SLIPS-modified implants also decrease macrophage inflammatory cytokine expression in vitro, which likely contributed to the presence of a thinner fibrous capsule in the absence of bacterial challenge. SLIPS is an easily implementable technology that provides a promising approach to substantially reduce the risk of device infection and associated patient morbidity, as well as health care costs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Sensor and Energy Harvesting Materials · Tissue Engineering and Regenerative Medicine · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (80)
Show source-provided references
1. Multistate point-prevalence survey of health care-associated infections10.1056/NEJMoa1306801 ↗
2. Subclinical infection of the silicone breast implant surface as a possible cause of capsular contracture10.1007/BF00450610 ↗
3. Enhanced susceptibility to subcutaneous abscess formation and persistent infection around catheters is associated with sustained interleukin-1beta levels10.1128/IAI.68.3.1692-1695.2000 ↗
4. Increased colonization of indwelling medical devices by quorum-sensing mutants of staphylococcus epidermidis in vivo10.1086/424487 ↗
5. Peri-implant tissue is an important niche for staphylococcus epidermidis in experimental biomaterial-associated infection in mice10.1128/IAI.01262-06 ↗
6. Physiological heterogeneity in biofilms10.1038/nrmicro1838 ↗
7. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation10.1038/416740a ↗
8. A genetic basis for pseudomonas aeruginosa biofilm antibiotic resistance10.1038/nature02122 ↗
9. Compromised host defense on pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions10.4049/jimmunol.171.8.4329 ↗
10. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent10.1099/mic.0.27463-0 ↗
11. Bacterial biofilm shows persistent resistance to liquid wetting and gas penetration10.1073/pnas.1011033108 ↗
12. Biomaterial-centered infection: microbial adhesion versus tissue integration10.1126/science.3629258 ↗
13. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications10.1002/adma.200901407 ↗
14. Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment10.1126/scitranslmed.3004120 ↗
15. Evidence for van der waals adhesion in gecko setae10.1073/pnas.192252799 ↗
16. Combinatorial discovery of polymers resistant to bacterial attachment10.1038/nbt.2316 ↗
17. Bacterial adhesion on peg modified polyurethane surfaces10.1016/S0142-9612(97)00245-7 ↗
18. Self-assembled organic monolayers: model systems for studying adsorption of proteins at surfaces10.1126/science.252.5009.1164 ↗
19. Grafted ionomer complexes and their effect on protein adsorption on silica and polysulfone surfaces10.1007/s00396-010-2295-6 ↗
20. Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms10.1002/adma.201001215 ↗
21. Antibacterial coatings on titanium implants, Journal of biomedical materials research. Part B
22. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides10.1073/pnas.0708254105 ↗
23. Bacterial biofilms: a common cause of persistent infections10.1126/science.284.5418.1318 ↗
24. Bacterial biofilms: from the natural environment to infectious diseases10.1038/nrmicro821 ↗
25. Bacterial retention on superhydrophobic titanium surfaces fabricated by femtosecond laser ablation10.1021/la104607g ↗
26. Recent developments in superhydrophobic surfaces and their relevance to marine fouling A review10.1080/08927010600980223 ↗
27. Robust omniphobic surfaces10.1073/pnas.0804872105 ↗
28. Retention of bacteria on a substratum surface with micro-patterned hydrophobicity10.1111/j.1574-6968.2000.tb09249.x ↗
29. Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity10.1038/nature10447 ↗
30. Liquid-infused structured surfaces with exceptional anti-biofouling performance10.1073/pnas.1201973109 ↗
31. Insect aquaplaning: Nepenthes pitcher plants capture prey with the peristome, a fully wettable water-lubricated anisotropic surface10.1073/pnas.0405885101 ↗
32. Liquid-infused nanostructured surfaces with extreme anti-ice and anti-frost performance10.1021/nn302310q ↗
33. Fabrics coated with lubricated nanostructures display robust omniphobicity10.1088/0957-4484/25/1/014019 ↗
34. Self-replenishing vascularized fouling-release surfaces10.1021/am503150y ↗
35. A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling10.1038/nbt.3020 ↗
36. Mesh in laparoscopic large hiatal hernia repair: a systematic review of the literature10.1007/s00464-013-3036-y ↗
37. Temporary abdominal closure with polytetrafluoroethylene prosthetic mesh in critically ill non-trauma patients10.1007/s10029-014-1267-z ↗
38. Ventral hernia repair with synthetic, composite, and biologic mesh: characteristics, indications, and infection profile10.1089/sur.2012.123 ↗
39. The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery10.1016/j.jvs.2014.01.062 ↗
40. Smaller-sized expanded polytetrafluoroethylene conduits with a fan-shaped valve and bulging sinuses for right ventricular outflow tract reconstruction10.1016/j.athoracsur.2016.03.027 ↗
41. Safety and efficacy of expanded polytetrafluoroethylene mplants in the surgical management of traumatic nasal deformity10.1001/jamaoto.2015.1122 ↗
42. The use of expanded polytetrafluoroethylene (gore-tex) in rhinoplasty. A 6-year experience10.1001/archotol.1995.01890100043007 ↗
43. Forehead augmentation with alloplastic implants10.1016/j.fsc.2009.11.006 ↗
44. Deep prosthesis infection in incisional hernia repair: predictive factors and clinical outcome10.1080/110241501750243815 ↗
45. Infection of ptfe grafts used to create arteriovenous fistulas for hemodialysis access10.1007/s100169910090 ↗
46. The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon collaborative study group10.1016/S0161-6420(97)30168-7 ↗
47. Perfluorocarbon-based oxygen carriers: review of products and trials10.1111/j.1525-1594.2009.00944.x ↗
48. Double endotamponade with perfluorodecalin and silicone oil in retinal detachment surgery. Https://clinicaltrials.Gov/show/nct01959568.
49. Virulence factor expression by gram-positive cocci exposed to subinhibitory concentrations of linezolid10.1093/jac/dkf192 ↗
50. Phenotypic non-equivalence of murine (monocyte-) macrophage cells in biomaterial and inflammatory models10.1002/jbm.a.31930 ↗
51. Host defence against staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (pmn)10.1016/j.molimm.2009.01.020 ↗
52. Targeting macrophage activation for the prevention and treatment of staphylococcus aureus biofilm infections10.4049/jimmunol.1202348 ↗
53. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo10.4049/jimmunol.1002794 ↗
54. Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models10.1128/AAC.47.9.2740-2748.2003 ↗
55. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model10.1128/IAI.67.5.2627-2632.1999 ↗
56. Antimicrobial peptide melimine coating for titanium and its in vivo antibacterial activity in rodent subcutaneous infection models10.1016/j.biomaterials.2016.01.063 ↗
57. A novel soft tissue model for biomaterial-associated infection and inflammation - bacteriological, morphological and molecular observations10.1016/j.biomaterials.2014.11.032 ↗
58. The basic science of wound healing10.1097/01.prs.0000225430.42531.c2 ↗
59. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The osiris collaborative study group10.1128/JCM.36.10.2932-2939.1998 ↗
60. Detection of subclinical infection in significant breast implant capsules10.1097/01.PRS.0000054768.14922.44 ↗
61. The susceptibility of prosthetic biomaterials to infection10.1007/s00464-004-8810-4 ↗
62. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy10.1086/592973 ↗
63. Anti-bacterial effects of poly-n-acetyl-glucosamine nanofibers in cutaneous wound healing: requirement for akt110.1371/journal.pone.0018996 ↗
64. A potential new pathway for staphylococcus aureus dissemination: the silent survival of s. Aureus phagocytosed by human monocyte-derived macrophages10.1371/journal.pone.0001409 ↗
65. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
66. Scott · 2009
67. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect10.1172/JCI111305 ↗
68. Pathogenesis of implant-associated infection: the role of the host10.1007/s00281-011-0275-7 ↗
69. Subcutaneous abscess formation around catheters induced by viable and nonviable staphylococcus epidermidis as well as by small amounts of bacterial cell wall components10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y ↗
70. Tissue around catheters is a niche for bacteria associated with medical device infection10.1097/CCM.0b013e3181818268 ↗
71. Hierarchical or not? Effect of the length scale and hierarchy of the surface roughness on omniphobicity of lubricant-infused substrates10.1021/nl4003969 ↗
72. Transparency and damage tolerance of patternable omniphobic lubricated surfaces based on inverse colloidal monolayers10.1038/ncomms3176 ↗
73. The effects of porosity on endothelialization of eptfe implanted in subcutaneous and adipose tissue10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I ↗
74. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro10.1002/jbm.a.32893 ↗
75. Plasma protein adsorbed biomedical polymers: activation of human monocytes and induction of interleukin 110.1002/jbm.820230602 ↗
76. Biomaterial-associated infection: locating the finish line in the race for the surface10.1126/scitranslmed.3004528 ↗
77. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions10.1186/cc364 ↗
78. Stability of surface-immobilized lubricant interfaces under flow10.1021/cm504652g ↗
79. Staphylococcus epidermidis originating from titanium implants infects surrounding tissue and immune cells10.1016/j.actbio.2014.08.012 ↗
80. Extremely durable biofouling-resistant metallic surfaces based on electrodeposited nanoporous tungstite films on steel10.1038/ncomms9649 ↗